Published June 2014 | Version Supplemental Material + Accepted Version
Journal Article Open

PDZ affinity chromatography: A general method for affinity purification of proteins based on PDZ domains and their ligands

Abstract

PDZ (PSD-95, DiscsLarge, ZO1) domains function in nature as protein binding domains within scaffold and membrane-associated proteins. They comprise ∼90 residues and make specific, high affinity interactions with complementary C-terminal peptide sequences, with other PDZ domains, and with phospholipids. We hypothesized that the specific, strong interactions of PDZ domains with their ligands would make them well suited for use in affinity chromatography. Here we describe a novel affinity chromatography method applicable for the purification of proteins that contain PDZ domain-binding ligands, either naturally or introduced by genetic engineering. We created a series of affinity resins comprised of PDZ domains from the scaffold protein PSD-95, or from neuronal nitric oxide synthase (nNOS), coupled to solid supports. We used them to purify heterologously expressed neuronal proteins or protein domains containing endogenous PDZ domain ligands, eluting the proteins with free PDZ domain peptide ligands. We show that Proteins of Interest (POIs) lacking endogenous PDZ domain ligands can be engineered as fusion products containing C-terminal PDZ domain ligand peptides or internal, N- or C-terminal PDZ domains and then can be purified by the same method. Using this method, we recovered recombinant GFP fused to a PDZ-domain ligand in active form as verified by fluorescence yield. Similarly, chloramphenicol acetyltransferase (CAT) and β-Galactosidase (LacZ) fused to a C-terminal PDZ domain ligand or an N-terminal PDZ domain were purified in active form as assessed by enzymatic assay. In general, PDZ domains and ligands derived from PSD-95 were superior to those from nNOS for this method. PDZ Domain Affinity Chromatography promises to be a versatile and effective method for purification of a wide variety of natural and recombinant proteins.

Additional Information

© 2014 Elsevier Inc. Received 25 December 2013. and in revised form 24 February 2014. Available online 6 March 2014. This work was supported by grants from the Gordon and Betty Moore Foundation, the Hicks Foundation for Alzheimer's Research, the Allen and Lenabelle Davis Foundation, and from National Institutes of Health Grant MH095095 to MBK. WGW IV was supported by the National Science Foundation Graduate Research Fellowship under Grant No. 2006019582 and the National Institutes of Health under Grant No. NIH/NRSA 5 T32 GM07616. We thank Kathryn M. Ivanetich for her careful editing and review of the manuscript, Jost Vielmetter and Mark Welch for technical discussions and Leslie Schenker for technical assistance.

Attached Files

Accepted Version - nihms576163.pdf

Supplemental Material - 1-s2.0-S1046592814000497-fx1.jpg

Supplemental Material - 1-s2.0-S1046592814000497-fx2.jpg

Supplemental Material - 1-s2.0-S1046592814000497-fx3.jpg

Files

1-s2.0-S1046592814000497-fx1.jpg

Files (1.6 MB)

Name Size Download all
md5:9ef177dbb6d26848910db5e42ed53e1e
33.2 kB Preview Download
md5:1b896d36310499650075d85aedf516e1
80.3 kB Preview Download
md5:8b7de3c4f32751a109056599451bc56b
89.9 kB Preview Download
md5:478f9ee67df0f561276623adfc0eacca
1.4 MB Preview Download

Additional details

Identifiers

PMCID
PMC4024478
Eprint ID
44429
DOI
10.1016/j.pep.2014.02.015
Resolver ID
CaltechAUTHORS:20140320-145341209

Funding

Gordon and Betty Moore Foundation
Hicks Foundation for Alzheimer's Research
Allen and Lenabelle Davis Foundation
NIH
MH095095
NSF Graduate Research Fellowship
2006019582
NIH Predoctoral Fellowship
5 T32 GM07616

Dates

Created
2014-03-24
Created from EPrint's datestamp field
Updated
2021-11-10
Created from EPrint's last_modified field